|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
NL8300698A
(nl)
|
1983-02-24 |
1984-09-17 |
Univ Leiden |
Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
DK122686D0
(da)
|
1986-03-17 |
1986-03-17 |
Novo Industri As |
Fremstilling af proteiner
|
|
FR2613624B1
(fr)
|
1987-04-10 |
1990-11-23 |
Roussy Inst Gustave |
Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
|
|
EP0433299B1
(en)
|
1988-08-02 |
1998-05-06 |
Gastro Services Pty. Limited (ACN 002 994 890) |
Treatment of gastro-intestinal disorders
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
KR100225087B1
(ko)
|
1990-03-23 |
1999-10-15 |
한스 발터라벤 |
피타아제의 식물내 발현
|
|
CA2082279C
(en)
|
1990-05-09 |
2007-09-04 |
Grethe Rasmussen |
Cellulase preparation comprising an endoglucanase enzyme
|
|
GB9107305D0
(en)
|
1991-04-08 |
1991-05-22 |
Unilever Plc |
Probiotic
|
|
DE69316801T2
(de)
|
1992-07-20 |
1998-05-20 |
Yakult Honsha Kk |
Spezies-Spezifische Oligonukleotide gegen Bifidobakterien und Verfahren zum Nachweis unter Verwendung derselben
|
|
DE69332030T2
(de)
|
1992-12-10 |
2002-10-02 |
Dsm N.V., Heerlen |
Herstellung von heterologen proteinen in filamentösen fungi
|
|
US5741665A
(en)
|
1994-05-10 |
1998-04-21 |
University Of Hawaii |
Light-regulated promoters for production of heterologous proteins in filamentous fungi
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
AUPM823094A0
(en)
|
1994-09-16 |
1994-10-13 |
Goodman Fielder Limited |
Probiotic compositions
|
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
|
RU2078815C1
(ru)
|
1995-01-17 |
1997-05-10 |
Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского |
Штамм бактерий bifidobacterium breve, используемый для получения бактерийных лечебно-профилактических бифидосодержащих препаратов
|
|
JPH08259450A
(ja)
|
1995-03-17 |
1996-10-08 |
Nichinichi Seiyaku Kk |
インターフェロン産生増強剤
|
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
AUPN698495A0
(en)
|
1995-12-06 |
1996-01-04 |
Pharma Pacific Pty Ltd |
Improved therapeutic formulation and method
|
|
SE508045C2
(sv)
|
1996-02-26 |
1998-08-17 |
Arla Ekonomisk Foerening |
Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
|
|
DE69738975D1
(de)
|
1996-03-20 |
2008-10-23 |
Univ New South Wales Kensingto |
Veränderung der mikrobenflora im verdauungstrakt
|
|
AUPN881396A0
(en)
|
1996-03-20 |
1996-04-18 |
Arnott's Biscuits Limited |
Enhancement of microbial colonization of the gastrointestinal tract
|
|
DK0894126T3
(da)
|
1996-03-27 |
2006-06-12 |
Novozymes As |
Alkalisk phosphatase-deficient trådformet svamp
|
|
US6033864A
(en)
|
1996-04-12 |
2000-03-07 |
The Regents Of The University Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
|
|
SE9604322D0
(sv)
|
1996-11-25 |
1996-11-25 |
Astra Ab |
Bacterial antigens and vaccine compositions II
|
|
WO1998043081A1
(en)
|
1997-03-26 |
1998-10-01 |
Ligand Pharmaceuticals Incorporated |
Treatment of gastrointestinal disease with ppar modulators
|
|
SE511524C2
(sv)
|
1997-06-02 |
1999-10-11 |
Essum Ab |
Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
|
|
US5925657A
(en)
|
1997-06-18 |
1999-07-20 |
The General Hospital Corporation |
Use of PPARγ agonists for inhibition of inflammatory cytokine production
|
|
AUPO758297A0
(en)
|
1997-06-27 |
1997-07-24 |
Rowe, James Baber |
Control of acidic gut syndrome
|
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
|
IT1298918B1
(it)
|
1998-02-20 |
2000-02-07 |
Mendes Srl |
Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
|
|
DE19826928A1
(de)
|
1998-06-17 |
1999-12-23 |
Novartis Consumer Health Gmbh |
Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
|
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
|
US7090973B1
(en)
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
|
DE60005973T2
(de)
|
1999-08-27 |
2004-05-13 |
Eli Lilly And Co., Indianapolis |
Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren
|
|
PL203212B1
(pl)
|
2000-02-08 |
2009-09-30 |
Dsm Ip Assets Bv |
Zastosowanie trwałej w kwasie proteazy w karmie zwierzęcej oraz w wytwarzaniu kompozycji do stosowania w karmie zwierzęcej, dodatek do karmy zwierzęcej, kompozycja karmy zwierzęcej i sposób obróbki białek roślinnych
|
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
WO2002042328A2
(en)
|
2000-11-27 |
2002-05-30 |
Washington University |
Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon
|
|
DE10101793A1
(de)
|
2001-01-17 |
2002-08-01 |
Manfred Nilius |
Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen
|
|
EP1227152A1
(en)
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Bacterial strain and genome of bifidobacterium
|
|
KR100437497B1
(ko)
|
2001-03-07 |
2004-06-25 |
주식회사 프로바이오닉 |
로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
|
|
EP1243273A1
(en)
|
2001-03-22 |
2002-09-25 |
Societe Des Produits Nestle S.A. |
Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
|
|
DE60141773D1
(de)
*
|
2001-04-20 |
2010-05-20 |
Inst Systems Biology |
Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren
|
|
EP1260227A1
(en)
|
2001-05-23 |
2002-11-27 |
Societe Des Produits Nestle S.A. |
Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
|
|
US20030092163A1
(en)
|
2001-07-26 |
2003-05-15 |
Collins John Kevin |
Probiotic bifidobacterium strains
|
|
WO2003022255A2
(en)
|
2001-09-05 |
2003-03-20 |
Vsl Pharmaceuticals, Inc. |
Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
|
|
GB0127916D0
(en)
|
2001-11-21 |
2002-01-16 |
Rowett Res Inst |
Method
|
|
JP2005518195A
(ja)
|
2001-11-27 |
2005-06-23 |
ワシントン・ユニバーシティ |
治療用タンパク質および治療方法
|
|
CA2860702C
(en)
*
|
2001-12-17 |
2019-02-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
|
US7101565B2
(en)
|
2002-02-05 |
2006-09-05 |
Corpak Medsystems, Inc. |
Probiotic/prebiotic composition and delivery method
|
|
DE10206995B4
(de)
|
2002-02-19 |
2014-01-02 |
Orthomol Pharmazeutische Vertriebs Gmbh |
Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
|
|
JP2003261453A
(ja)
|
2002-03-11 |
2003-09-16 |
Nippon Berumu Kk |
Ｅ．フェカリスからなる抗腫瘍剤及び放射線防護剤
|
|
SI1565547T2
(sl)
|
2002-06-28 |
2013-02-28 |
Biosearch S.A. |
Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
|
|
US20040005304A1
(en)
|
2002-07-08 |
2004-01-08 |
Mak Wood, Inc. |
Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
|
|
GB0307026D0
(en)
|
2003-03-27 |
2003-04-30 |
Rowett Res Inst |
Bacterial supplement
|
|
EP1481681A1
(en)
|
2003-05-30 |
2004-12-01 |
Claudio De Simone |
Lactic acid bacteria combination and compositions thereof
|
|
GB0316915D0
(en)
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
|
WO2005007834A1
(en)
|
2003-07-23 |
2005-01-27 |
Probionic Corp. |
Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
|
|
US7485325B2
(en)
|
2003-08-06 |
2009-02-03 |
Gayle Dorothy Swain |
Animal food supplement compositions and methods of use
|
|
JP4683881B2
(ja)
|
2003-08-27 |
2011-05-18 |
有限会社アーク技研 |
抗腫瘍活性剤
|
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
|
WO2005030133A2
(en)
|
2003-09-22 |
2005-04-07 |
Yale University |
Treatment with agonists of toll-like receptors
|
|
GB0323039D0
(en)
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
|
DK1675481T3
(da)
|
2003-10-24 |
2009-01-19 |
Nutricia Nv |
Synbiotisk præparat til börn
|
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
|
AU2004298384A1
(en)
|
2003-12-17 |
2005-06-30 |
N.V. Nutricia |
Lactic acid producing bacteria and lung function
|
|
ES2235642B2
(es)
|
2003-12-18 |
2006-03-01 |
Gat Formulation Gmbh |
Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos.
|
|
AU2005227320B2
(en)
|
2004-03-22 |
2010-06-24 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, National Insitutes Of Health |
Cellular and viral inactivation
|
|
EP1755668A2
(en)
*
|
2004-05-07 |
2007-02-28 |
Hans-Gustaf Ljunggren |
Adjuvants
|
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
JP5070051B2
(ja)
|
2004-06-07 |
2012-11-07 |
クー バイオロジックス インク． |
癌を治療するための細菌組成物
|
|
ATE361101T1
(de)
|
2004-08-24 |
2007-05-15 |
Nutricia Nv |
Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
|
|
US20060062742A1
(en)
|
2004-09-21 |
2006-03-23 |
The Procter & Gamble Company |
Compositions for reduction of human malodor
|
|
KR100468522B1
(ko)
|
2004-10-12 |
2005-01-31 |
주식회사 프로바이오닉 |
코로나바이러스와 돼지 써코바이러스 2형의 생육을 억제하는 신규한 내산성 프로바이오틱 엔테로코커스훼시움 프로바이오-63
|
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
|
ITMI20042189A1
(it)
|
2004-11-16 |
2005-02-16 |
Anidral Srl |
Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
|
|
AU2006217160B2
(en)
|
2005-02-28 |
2011-09-15 |
N.V. Nutricia |
Nutritional composition with probiotics
|
|
US20090233888A1
(en)
|
2005-03-23 |
2009-09-17 |
Usc Stevens, University Of Southern California |
Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
|
|
WO2006102350A1
(en)
|
2005-03-23 |
2006-09-28 |
Washington University In St. Louis |
The use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota
|
|
JP2006265212A
(ja)
*
|
2005-03-25 |
2006-10-05 |
Institute Of Physical & Chemical Research |
Ｉｌ−２１産生誘導剤
|
|
US20100233312A9
(en)
|
2005-04-11 |
2010-09-16 |
The Procter & Gamble Company |
Compositions comprising probiotic and sweetener components
|
|
EP1714660A1
(en)
|
2005-04-21 |
2006-10-25 |
N.V. Nutricia |
Uronic acid and probiotics
|
|
ES2382873T3
(es)
|
2005-04-26 |
2012-06-14 |
Teagasc, The Agriculture And Food Development Authority |
Composición probiótica adecuada para animales
|
|
RU2494107C2
(ru)
|
2005-05-09 |
2013-09-27 |
Оно Фармасьютикал Ко., Лтд. |
Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
|
|
US7572474B2
(en)
|
2005-06-01 |
2009-08-11 |
Mead Johnson Nutrition Company |
Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
|
|
US8075934B2
(en)
|
2008-10-24 |
2011-12-13 |
Mead Johnson Nutrition Company |
Nutritional composition with improved digestibility
|
|
JP2007084533A
(ja)
|
2005-08-24 |
2007-04-05 |
Prima Meat Packers Ltd |
免疫応答調節組成物及び該組成物を有効成分とする食品
|
|
US7625704B2
(en)
|
2005-08-31 |
2009-12-01 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for identifying bacteria associated with bacteria vaginosis
|
|
PL1933869T3
(pl)
|
2005-09-01 |
2010-06-30 |
Merck Sharp & Dohme |
Zastosowanie antagonistów IL-23 i IL-17 do leczenia autoimmunologicznej zapalnej choroby oczu
|
|
WO2007035057A1
(en)
|
2005-09-23 |
2007-03-29 |
Gwangju Institute Of Science And Technology |
Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients
|
|
EP1776877A1
(en)
|
2005-10-21 |
2007-04-25 |
N.V. Nutricia |
Method for stimulating the intestinal flora
|
|
MY144556A
(en)
|
2005-10-24 |
2011-09-30 |
Nestec Sa |
Dietary fiber formulation and method of administration
|
|
JP2007116991A
(ja)
|
2005-10-28 |
2007-05-17 |
Eternal Light General Institute Inc |
機能性食品
|
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
|
WO2007064732A1
(en)
|
2005-12-01 |
2007-06-07 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders and microbial diseases
|
|
US8889149B2
(en)
|
2006-02-16 |
2014-11-18 |
Wayne State University |
Use of flagellin to prevent and treat gram negative bacterial infection
|
|
US20080260898A1
(en)
|
2006-03-17 |
2008-10-23 |
Marko Stojanovic |
Compositions comprising probiotic and sweetener components
|
|
JP5031249B2
(ja)
|
2006-03-22 |
2012-09-19 |
学校法人北里研究所 |
炎症抑制作用のある菌体含有組成物
|
|
EP2040724B1
(en)
|
2006-05-18 |
2011-10-05 |
Biobalance Llc |
Biotherapeutic compositions comprising probiotic escherichia coli and metronidazole and uses thereof
|
|
AU2007267560B2
(en)
|
2006-05-26 |
2010-10-21 |
Nestec S.A. |
Methods of use and nutritional compositions of Touchi Extract
|
|
WO2007140613A1
(en)
|
2006-06-06 |
2007-12-13 |
Mcgill University |
Fermented milk product and use thereof
|
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
|
AU2007280272A1
(en)
|
2006-08-04 |
2008-02-07 |
Shs International Ltd |
Protein free formula
|
|
WO2008031438A2
(en)
|
2006-09-13 |
2008-03-20 |
Region Hovedstaden V/Gentofte Hospital |
Treatment of asthma, eczema and/or allergy using non-pathogenic organisms
|
|
US20080069861A1
(en)
|
2006-09-19 |
2008-03-20 |
National Starch And Chemical Investment Holding Corporation |
Probiotic/Non-Probiotic Combinations
|
|
KR20120038021A
(ko)
|
2006-10-27 |
2012-04-20 |
화이자 프로덕츠 인코포레이티드 |
하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법
|
|
WO2008053444A2
(en)
|
2006-11-01 |
2008-05-08 |
The Procter & Gamble Company |
Treating a respiratory condition with bifidobacterium
|
|
EP1920781B1
(en)
|
2006-11-10 |
2015-03-04 |
Glycotope GmbH |
Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors
|
|
WO2008064489A1
(en)
|
2006-12-01 |
2008-06-05 |
Mcmaster University |
Probiotics to inhibit inflammation
|
|
EP2102350A4
(en)
|
2006-12-18 |
2012-08-08 |
Univ St Louis |
DARMMICROBIOMA AS A BIOMARKER AND THERAPEUTIC OBJECT FOR THE TREATMENT OF ADIPOSITAS OR ADIPOSITASCONDUCTIVE DISEASES
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
|
JP2008195635A
(ja)
|
2007-02-09 |
2008-08-28 |
Crossfield Bio Inc |
馬用乳酸菌製剤
|
|
WO2008106373A1
(en)
|
2007-02-28 |
2008-09-04 |
Mead Johnson Nutrition Company |
Product containing inactivated probiotic for children or infants
|
|
BRPI0809448A2
(pt)
|
2007-03-28 |
2014-09-09 |
Alimentary Health Ltd |
Cepas de bifidobacterium probióticas
|
|
CA2682242A1
(en)
|
2007-03-28 |
2008-10-02 |
Alimentary Health Limited |
Probiotic bifidobacterium longum strain
|
|
WO2008134450A2
(en)
|
2007-04-24 |
2008-11-06 |
Kemin Industries, Inc. |
Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115
|
|
EP1997499A1
(en)
|
2007-05-31 |
2008-12-03 |
Puleva Biotech, S.A. |
Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
|
|
EP1997905A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Nucleic acid amplification
|
|
EP1997907A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Bifidobacteria
|
|
EP1997906A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Lactobacillus
|
|
WO2008153377A1
(en)
|
2007-06-15 |
2008-12-18 |
N.V. Nutricia |
Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
|
|
EP2522358B1
(en)
|
2007-06-27 |
2016-11-09 |
Laboratorios Ordesa, S.l. |
Peptides against rotavirus infection
|
|
US20110027348A1
(en)
|
2007-08-27 |
2011-02-03 |
Janos Feher |
Composition and method inhibiting inflammation
|
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
US20100284979A1
(en)
|
2007-10-01 |
2010-11-11 |
University College Cork, National University Of Ireland, Cork |
Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria
|
|
WO2009049932A1
(en)
|
2007-10-20 |
2009-04-23 |
Universite De Liege |
Bifidobacterial species
|
|
AU2008317000B2
(en)
|
2007-10-26 |
2014-10-23 |
Brenda E. Moore |
Probiotic compositions and methods for inducing and supporting weight loss
|
|
ES2567079T3
(es)
|
2007-11-02 |
2016-04-19 |
Momenta Pharmaceuticals, Inc. |
Composiciones de polisacáridos que no son anticoagulantes
|
|
EP2065048A1
(en)
|
2007-11-30 |
2009-06-03 |
Institut Pasteur |
Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
|
|
EP2356992B1
(en)
|
2007-12-07 |
2017-08-16 |
N.V. Nutricia |
Bifidobactrium for dust mite allergy
|
|
WO2009079564A2
(en)
|
2007-12-17 |
2009-06-25 |
Emory University |
Immunogenic compositions and methods of use thereof
|
|
ES2343499B1
(es)
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
|
AU2009212295A1
(en)
|
2008-02-06 |
2009-08-13 |
The Procter & Gamble Company |
Compositions methods and kits for enhancing immune response to a respiratory condition
|
|
EP2103226A1
(en)
|
2008-03-18 |
2009-09-23 |
Friesland Brands B.V. |
Long-life probiotic food product
|
|
WO2009128949A2
(en)
*
|
2008-04-18 |
2009-10-22 |
Vaxinnate Corporation |
Compositions of dengue viral proteins and methods of use
|
|
AR071787A1
(es)
|
2008-05-13 |
2010-07-14 |
Glycotope Gmbh |
Procedimiento de fermentacion, alimento fermentado producido por dicho procedimiento y auxiliar de procesamiento
|
|
MX2008006546A
(es)
|
2008-05-21 |
2009-11-23 |
Sigma Alimentos Sa De Cv |
Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
|
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
|
CN101590081A
(zh)
|
2008-05-28 |
2009-12-02 |
青岛东海药业有限公司 |
凸腹真杆菌和两形真杆菌制剂及其应用
|
|
WO2009149149A1
(en)
|
2008-06-04 |
2009-12-10 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
EP2133088A3
(en)
|
2008-06-09 |
2010-01-27 |
Nestec S.A. |
Rooibos and inflammation
|
|
WO2009151315A1
(en)
|
2008-06-13 |
2009-12-17 |
N.V. Nutricia |
Nutritional composition for infants delivered via caesarean section
|
|
WO2009154463A2
(en)
|
2008-06-20 |
2009-12-23 |
Stichting Top Institute Food And Nutrition |
Butyrate as a medicament to improve visceral perception in humans
|
|
EP2138186A1
(en)
|
2008-06-24 |
2009-12-30 |
Nestec S.A. |
Probiotics, secretory IgA and inflammation
|
|
WO2010002241A1
(en)
|
2008-06-30 |
2010-01-07 |
N.V. Nutricia |
Nutritional composition for infants delivered via caesarean section
|
|
KR101017448B1
(ko)
|
2008-09-18 |
2011-02-23 |
주식회사한국야쿠르트 |
대장의 건강 증진 효능을 갖는 비피도박테리움 롱검 에이취와이8004 및 이를 유효성분으로 함유하는 제품
|
|
US20100074870A1
(en)
|
2008-09-19 |
2010-03-25 |
Bristol-Myers Squibb Company |
Probiotic infant products
|
|
US8137718B2
(en)
|
2008-09-19 |
2012-03-20 |
Mead Johnson Nutrition Company |
Probiotic infant products
|
|
KR101057357B1
(ko)
|
2008-09-22 |
2011-08-17 |
광주과학기술원 |
유산균 및 콜라겐을 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물 및 식품 조성물
|
|
EP2337569A4
(en)
|
2008-09-25 |
2013-04-03 |
Univ New York |
COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE STOMACH DARM, SKIN AND NOSE MICROBIOTA
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
EP2373182A1
(en)
|
2008-12-05 |
2011-10-12 |
Nestec S.A. |
Compositions for use in low-birth weight infants
|
|
US20120107279A1
(en)
|
2008-12-19 |
2012-05-03 |
Nestec S.A. |
Prevention and treatment of rotavirus diarrhoea
|
|
IT1392672B1
(it)
|
2009-01-12 |
2012-03-16 |
Wyeth Consumer Healthcare S P A |
Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
|
|
EP2403531A4
(en)
|
2009-03-05 |
2013-02-27 |
Abbott Lab |
IL-17 BINDING PROTEINS
|
|
JP5710876B2
(ja)
|
2009-03-26 |
2015-04-30 |
クロスフィールドバイオ株式会社 |
新規ビフィドバクテリウム属微生物およびその利用
|
|
BRPI1014800A8
(pt)
|
2009-05-07 |
2016-10-11 |
Tate & Lyle Ingredients France SAS |
"composição compreendendo alfa-(1,6) oligodextranas alfa-(1,2) ramificadas, método para preparar as referidas oligodextranas e uso das mesmas"
|
|
EP2251020A1
(en)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
|
|
US8784798B2
(en)
|
2009-05-11 |
2014-07-22 |
Nestec S.A. |
Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
|
|
EP2251022A1
(en)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Non-replicating micro-organisms and their immune boosting effect
|
|
KR20100128168A
(ko)
|
2009-05-27 |
2010-12-07 |
중앙대학교 산학협력단 |
공액 리놀레산 생산능이 우수한 신규한 균주
|
|
US20100311686A1
(en)
|
2009-06-03 |
2010-12-09 |
Kasper Lloyd H |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
|
WO2010143940A1
(en)
|
2009-06-12 |
2010-12-16 |
N.V. Nutricia |
Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
|
|
EP2443259A4
(en)
|
2009-06-16 |
2012-10-10 |
Univ Columbia |
BIOMARKERS ASSOCIATED WITH AUTISM AND USES THEREOF
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
US20120129794A1
(en)
|
2009-07-24 |
2012-05-24 |
Dowd Scot E |
Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
|
|
ES2664724T3
(es)
|
2009-08-18 |
2018-04-23 |
Nestec S.A. |
Composición nutricional que comprende cepas de Bifidobacterium longum y que reduce los síntomas de alergia alimentaria, especialmente en lactantes y niños
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
JP2013505289A
(ja)
|
2009-09-23 |
2013-02-14 |
トーマス・ジュリアス・ボロディ |
腸管感染症の治療法
|
|
EP2308498A1
(en)
|
2009-09-30 |
2011-04-13 |
Nestec S.A. |
Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
|
|
CA2776420A1
(en)
|
2009-10-05 |
2011-04-14 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
|
EP3144004A1
(en)
|
2009-10-06 |
2017-03-22 |
Scott Dorfner |
Antibiotic formulations providing reduced gastrointestinal side effects and clostridium difficile infection relapse, and related methods
|
|
CN107574131A
(zh)
|
2009-11-11 |
2018-01-12 |
营养健康有限公司 |
益生菌双歧杆菌菌株
|
|
US10212954B2
(en)
|
2009-12-18 |
2019-02-26 |
Colgate-Palmolive Company |
Pet food compositions including probiotics and methods of manufacture and use thereof
|
|
US20150104418A1
(en)
|
2014-12-18 |
2015-04-16 |
Microbios, Inc. |
Bacterial composition
|
|
FR2955774A1
(fr)
|
2010-02-02 |
2011-08-05 |
Aragan |
Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
|
|
NL2004200C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides in weight management.
|
|
NL2004201C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides to modulate the immune system.
|
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
|
JP5737646B2
(ja)
|
2010-03-24 |
2015-06-17 |
森下仁丹株式会社 |
抗アレルギー剤
|
|
EP2552464B1
(en)
|
2010-03-30 |
2018-02-28 |
Assistance Publique - Hôpitaux de Paris |
Use of bifidobacteria for preventing allergy in breastfed infants
|
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2011149335A1
(en)
|
2010-05-25 |
2011-12-01 |
N.V. Nutricia |
Immune imprinting nutritional composition
|
|
AU2011261528A1
(en)
|
2010-06-01 |
2013-01-10 |
Moore Research Enterprises Llc |
Cellular constituents from Bacteroides, compositions thereof, and therapeutic methods employing Bacteroides or cellular constituents thereof
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
TWI417054B
(zh)
|
2010-06-15 |
2013-12-01 |
Jen Shine Biotechnology Co Ltd |
新穎糞腸球菌ｌｊｓ－０１及其益生用途
|
|
EP2397145A1
(en)
|
2010-06-18 |
2011-12-21 |
Nestec S.A. |
L. johnsonii La1, B. longum NCC2705 and immune disorders
|
|
FR2962045B1
(fr)
|
2010-07-05 |
2012-08-17 |
Bifinove |
Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
|
|
TWI401086B
(zh)
|
2010-07-20 |
2013-07-11 |
Univ China Medical |
胚芽乳酸桿菌及其用途
|
|
NZ702796A
(en)
|
2010-07-26 |
2017-03-31 |
Qu Biologics Inc |
Immunogenic anti-inflammatory compositions
|
|
PH12013500224A1
(en)
|
2010-08-04 |
2013-04-08 |
Borody Thomas J |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
KR101250463B1
(ko)
|
2010-10-12 |
2013-04-15 |
대한민국 |
신생아 분변에서 분리한 내산소성 비피도박테리움 롱검 비피더스 유산균 및 이를 이용한 프로바이오틱 조성물
|
|
KR20130113476A
(ko)
|
2010-10-27 |
2013-10-15 |
?티백트 에이/에스 |
인터칼레이터 （ｉｎｔｅｒｃａｌａｔｏｒ） 분자를 포함하는 프로브에 의한 표적 ＤＮＡ 및 ＲＮＡ의 캡쳐
|
|
CN102031235B
(zh)
|
2010-11-09 |
2012-07-25 |
中国农业大学 |
一种粪肠球菌anse228及其应用
|
|
EP2455092A1
(en)
|
2010-11-11 |
2012-05-23 |
Nestec S.A. |
Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
|
|
WO2012071380A1
(en)
|
2010-11-24 |
2012-05-31 |
Oragenics, Inc. |
Use of bacteria to treat and prevent respiratory infections
|
|
CN102093967B
(zh)
|
2010-12-02 |
2013-01-30 |
中国农业科学院特产研究所 |
一株水貂源屎肠球菌及其应用
|
|
ES2389547B1
(es)
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
|
WO2012097012A1
(en)
|
2011-01-10 |
2012-07-19 |
Cleveland Biolabs, Inc. |
Use of toll-like receptor agonist for treating cancer
|
|
PL2481299T3
(pl)
|
2011-01-31 |
2017-09-29 |
Synformulas Gmbh |
Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
|
|
JP5840368B2
(ja)
|
2011-02-02 |
2016-01-06 |
カルピス株式会社 |
関節炎予防改善用物質
|
|
EP2672980B1
(en)
|
2011-02-09 |
2017-12-06 |
Lavivo AB |
Synbiotic compositions for restoration and reconstitution of gut microbiota
|
|
MX2013010343A
(es)
|
2011-03-09 |
2014-04-30 |
Univ Minnesota |
Composicion y metodos para el transplante de microbiota de colon.
|
|
BRPI1100857A2
(pt)
|
2011-03-18 |
2013-05-21 |
Alexandre Eduardo Nowill |
agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
|
|
WO2012140636A1
(en)
|
2011-04-11 |
2012-10-18 |
Alimentary Health Limited |
A probiotic formulation
|
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
MX2013012165A
(es)
|
2011-04-20 |
2014-06-11 |
Mico Bio Inc |
Composicion y metodo para mejorar una respuesta inmune.
|
|
JP6129821B2
(ja)
|
2011-05-13 |
2017-05-17 |
グリコシン リミテッド ライアビリティー カンパニー |
プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
|
|
KR20120133133A
(ko)
|
2011-05-30 |
2012-12-10 |
한국 한의학 연구원 |
생약 추출물 또는 이의 유산균 발효물을 포함하는 호흡기 질환의 예방 또는 치료용 조성물
|
|
US20140171339A1
(en)
|
2011-06-06 |
2014-06-19 |
The University Of North Carolina At Chapel Hill |
Methods and kits for detecting adenomas, colorectal cancer, and uses thereof
|
|
GB201110095D0
(en)
|
2011-06-15 |
2011-07-27 |
Danisco |
Method of treatment
|
|
JP2013005759A
(ja)
|
2011-06-24 |
2013-01-10 |
Kyodo Milk Industry Co Ltd |
マウス腸内菌叢の推測方法
|
|
WO2013005836A1
(ja)
|
2011-07-07 |
2013-01-10 |
長岡香料株式会社 |
フルクトース吸収阻害剤
|
|
WO2013008102A2
(en)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Methods and compositions for evaluating and/or treating chronic immune diseases
|
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
|
CN102304483A
(zh)
|
2011-08-12 |
2012-01-04 |
北京金泰得生物科技股份有限公司 |
一株饲用屎肠球菌及其应用
|
|
KR101261872B1
(ko)
|
2011-08-23 |
2013-05-14 |
대한민국 (식품의약품안전처장) |
장내 미생물 효소복합체 및 이의 제조방법
|
|
ES2662793T3
(es)
|
2011-09-14 |
2018-04-09 |
Nubiyota Llc |
Complementos de medio y métodos para cultivar microorganismos anaerobios gastrointestinales humanos
|
|
GB201117313D0
(en)
*
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
PT2750682T
(pt)
|
2011-10-11 |
2016-07-26 |
Achim Biotherapeutics Ab |
Composição compreendendo a flora intestinal cultivada anaerobiamente
|
|
CN103082292B
(zh)
|
2011-11-02 |
2015-03-04 |
深圳华大基因研究院 |
罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用
|
|
CN102373172B
(zh)
|
2011-11-03 |
2013-03-20 |
北京龙科方舟生物工程技术有限公司 |
一株屎肠球菌及其应用
|
|
CN116942833A
(zh)
|
2011-12-01 |
2023-10-27 |
国立大学法人 东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
|
ES2408279B1
(es)
|
2011-12-15 |
2014-09-09 |
Universidad De Las Palmas De Gran Canaria |
Bacteria acido láctica probiótica
|
|
ITBG20120010A1
(it)
|
2012-02-24 |
2013-08-25 |
Milano Politecnico |
Dispositivo per l'addestramento chirurgico
|
|
ITMI20120471A1
(it)
|
2012-03-26 |
2013-09-27 |
Giovanni Mogna |
Composizione a base di ceppi di batteri bifidobacterium longum in grado di aiutare il prolungamento della vita
|
|
JP5792105B2
(ja)
|
2012-03-27 |
2015-10-07 |
森永乳業株式会社 |
ラクト−ｎ−ビオースｉの製造方法
|
|
WO2013146319A1
(ja)
|
2012-03-30 |
2013-10-03 |
味の素株式会社 |
糖尿病誘起細菌
|
|
US20130280724A1
(en)
|
2012-04-11 |
2013-10-24 |
Nestec Sa |
Methods for diagnosing impending diarrhea
|
|
WO2013154725A1
(en)
|
2012-04-13 |
2013-10-17 |
Trustees Of Boston College |
Prebiotic compositions and methods of use
|
|
GB201206599D0
(en)
|
2012-04-13 |
2012-05-30 |
Univ Manchester |
Probiotic bacteria
|
|
EP3686284A1
(en)
|
2012-05-18 |
2020-07-29 |
Genome Research Limited |
Methods and groups
|
|
ES2436251B1
(es)
|
2012-05-25 |
2014-10-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas.
|
|
AU2013271336B2
(en)
|
2012-06-04 |
2017-11-30 |
Centre For Digestive Diseases |
Compositions and methods for treating Crohn's Disease and related conditions and infections
|
|
CN106620189B
(zh)
|
2012-06-06 |
2021-11-19 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
|
US9676847B2
(en)
|
2012-06-25 |
2017-06-13 |
Orega Biotech |
IL-17 antagonist antibodies
|
|
JP6368306B2
(ja)
|
2012-07-31 |
2018-08-01 |
ネステク ソシエテ アノニム |
炎症性腸疾患（ｉｂｄ）患者の筋骨格の健康を促進させるための栄養組成物
|
|
WO2014019271A1
(en)
|
2012-08-01 |
2014-02-06 |
Bgi Shenzhen |
Biomarkers for diabetes and usages thereof
|
|
WO2014036182A2
(en)
|
2012-08-29 |
2014-03-06 |
California Institute Of Technology |
Diagnosis and treatment of autism spectrum disorder
|
|
CN104936581A
(zh)
|
2012-08-29 |
2015-09-23 |
萨利克斯药品有限公司 |
用于治疗便秘和相关胃肠道疾病和疾病状态的泻药组合物和方法
|
|
WO2014043593A2
(en)
|
2012-09-13 |
2014-03-20 |
Massachusetts Institute Of Technology |
Programmable drug delivery profiles of tumor-targeted bacteria
|
|
KR101473058B1
(ko)
|
2012-09-19 |
2014-12-16 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
|
CN103652322B
(zh)
|
2012-09-21 |
2016-02-10 |
临沂思科生物科技有限公司 |
一种含乳酸菌的复合益生菌饲料添加剂的制备方法
|
|
EP3401396A1
(en)
|
2012-10-03 |
2018-11-14 |
Metabogen AB |
Treating or preventing atherosclerosis or associated diseases by beta-carotene
|
|
FR2997091B1
(fr)
|
2012-10-22 |
2016-05-06 |
Fond Mediterranee Infection |
Utilisation d'un compose antioxydant pour la culture de bacteries sensibles a la tension en oxygene
|
|
US9839657B2
(en)
|
2012-10-30 |
2017-12-12 |
Deerland Enzymes, Inc. |
Prebiotic compositions comprising one or more types of bacteriophage
|
|
CN104755092A
(zh)
|
2012-10-30 |
2015-07-01 |
雀巢产品技术援助有限公司 |
用于递送协同免疫作用的包含微粒和益生菌的组合物
|
|
EP2914135A1
(en)
|
2012-11-01 |
2015-09-09 |
Rijksuniversiteit Groningen |
Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
|
|
WO2014075745A1
(en)
|
2012-11-19 |
2014-05-22 |
Université Catholique de Louvain |
Use of akkermansia for treating metabolic disorders
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
CA3212215A1
(en)
|
2012-11-23 |
2014-05-30 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
CA2896795A1
(en)
|
2012-11-26 |
2014-05-30 |
Thomas Julius Borody |
Compositions for the restoration of a fecal microbiota and methods for making and using them
|
|
DK2931897T3
(en)
|
2012-12-12 |
2018-02-05 |
Broad Inst Inc |
CONSTRUCTION, MODIFICATION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTICAL APPLICATIONS
|
|
CA2894684A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Engineering and optimization of improved crispr-cas systems, methods and enzyme compositions for sequence manipulation in eukaryotes
|
|
DK2931898T3
(en)
|
2012-12-12 |
2016-06-20 |
Massachusetts Inst Technology |
CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS
|
|
US20140193464A1
(en)
|
2013-01-08 |
2014-07-10 |
Imagilin Technology, Llc |
Effects of probiotics on humans and animals under environmental or biological changes
|
|
HK1218560A1
(zh)
|
2013-02-04 |
2017-02-24 |
Seres Therapeutics, Inc. |
组成与方法
|
|
CA2899925A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Therapeutics, Inc. |
Compositions and methods for inhibition of pathogenic bacterial growth
|
|
EP2958575B1
(en)
|
2013-02-22 |
2019-04-03 |
The Regents of The University of California |
Composition comprising lactobaccilus johnsonii 456 and its use in treating or preventing diseases
|
|
CN105228635A
(zh)
|
2013-03-05 |
2016-01-06 |
格罗宁根大学 |
Faecalibacterium prausnitzii HTF-F（DSM 26943）在抑制炎症中的应用
|
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
|
AU2014239883B2
(en)
|
2013-03-14 |
2019-01-17 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
EP2967077A4
(en)
|
2013-03-15 |
2016-09-14 |
Seres Therapeutics Inc |
NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
|
|
WO2014150094A1
(en)
|
2013-03-15 |
2014-09-25 |
University Of Florida Research Foundation, Inc. |
Butyrogenic bacteria as probiotics to treat clostridium difficile
|
|
CN103142656A
(zh)
|
2013-03-18 |
2013-06-12 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备防治结肠癌组合物中的应用
|
|
CN103156888A
(zh)
|
2013-03-18 |
2013-06-19 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备治疗炎症性肠病组合物中的应用
|
|
CN103146620A
(zh)
|
2013-03-25 |
2013-06-12 |
广州知光生物科技有限公司 |
具有益生菌特性的脆弱拟杆菌
|
|
JP2014196260A
(ja)
|
2013-03-29 |
2014-10-16 |
公立大学法人奈良県立医科大学 |
慢性閉塞性肺疾患の予防又は治療用組成物
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
JP2016521284A
(ja)
|
2013-05-10 |
2016-07-21 |
カリフォルニア インスティチュート オブ テクノロジー |
大腸ガンのプロバイオティクスによる防止および処置
|
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
PL3003330T4
(pl)
|
2013-06-05 |
2019-03-29 |
Rebiotix, Inc. |
Terapia przywracająca mikrobiota (MRT), kompozycje i sposoby wytwarzania
|
|
US20160120915A1
(en)
|
2013-06-10 |
2016-05-05 |
New York University |
Methods for manipulating immune responses by altering microbiota
|
|
WO2014200334A1
(en)
|
2013-06-14 |
2014-12-18 |
N.V. Nutricia |
Synbiotic composition for treatment of infections in allergic patients
|
|
WO2015003001A1
(en)
|
2013-07-01 |
2015-01-08 |
The Washington University |
Methods for identifying supplements that increase gut colonization by an isolated bacterial species, and compositions derived therefrom
|
|
WO2015003305A1
(zh)
|
2013-07-08 |
2015-01-15 |
吉瑞高新科技股份有限公司 |
电子烟盒
|
|
WO2015006355A2
(en)
|
2013-07-09 |
2015-01-15 |
Puretech Ventures, Llc |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
|
JP6637885B2
(ja)
|
2013-07-21 |
2020-01-29 |
ペンデュラム セラピューティクス， インコーポレイテッド |
マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
|
|
WO2015017625A1
(en)
|
2013-07-31 |
2015-02-05 |
Wikifoods, Inc. |
Encapsulated functional food compositions
|
|
EP3033091B1
(en)
|
2013-08-16 |
2022-09-07 |
Versitech Limited |
Probiotic composition and use thereof in the prevention and treatment of hepatocellular carcinoma
|
|
CN103509741B
(zh)
|
2013-08-22 |
2015-02-18 |
河北农业大学 |
布劳特菌auh-jld56及其在牛蒡苷元转化中的应用
|
|
ITMI20131467A1
(it)
|
2013-09-06 |
2015-03-07 |
Sofar Spa |
Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
|
|
US10203329B2
(en)
|
2013-09-12 |
2019-02-12 |
The Johns Hopkins University |
Biofilm formation to define risk for colon cancer
|
|
DK3071052T3
(da)
|
2013-10-18 |
2020-04-27 |
Innovachildfood Ab |
Ernæringsmæssigt afbalanceret sammensat måltid til spædbørn og småbørn og fremgangsmåde til fremstilling af måltidet
|
|
PL229020B1
(pl)
|
2013-11-13 |
2018-05-30 |
Inst Biotechnologii Surowic I Szczepionek Biomed Spolka Akcyjna |
Nowy szczep Bifidobacterium breve
|
|
EP3074027B1
(en)
|
2013-11-25 |
2024-12-18 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
CN103981115B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其应用
|
|
CN103981117B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其培养方法和应用
|
|
CN103820363B
(zh)
|
2014-01-27 |
2016-02-24 |
福建省农业科学院生物技术研究所 |
一种屎肠球菌菌粉的制备与应用
|
|
CN103865846B
(zh)
|
2014-02-27 |
2016-03-30 |
扬州绿保生物科技有限公司 |
一种屎肠球菌及其制备方法
|
|
CN103849590B
(zh)
|
2014-03-25 |
2016-07-06 |
上海交通大学 |
一株耐酸短双歧杆菌BB8dpH及其应用
|
|
KR101683474B1
(ko)
|
2014-03-26 |
2016-12-08 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
|
US9783858B2
(en)
|
2014-04-02 |
2017-10-10 |
Northwestern University |
Altered microbiome of chronic pelvic pain
|
|
KR101583546B1
(ko)
|
2014-04-09 |
2016-01-11 |
국립암센터 |
유전자 다형성을 이용한 소라페닙 치료에 대한 반응성 예측방법
|
|
JP6617935B2
(ja)
|
2014-04-10 |
2019-12-11 |
国立研究開発法人理化学研究所 |
Ｔｈ１７細胞の誘導のための組成物及び方法
|
|
CN104195075B
(zh)
|
2014-08-14 |
2017-04-19 |
生合生物科技股份有限公司 |
一种屎肠球菌ef08及包含它的饲料添加物和饲料
|
|
WO2015168534A1
(en)
|
2014-05-02 |
2015-11-05 |
Novogy, Inc. |
Therapeutic treatment of gastrointestinal microbial imbalances through competitive microbe displacement
|
|
PL3139914T3
(pl)
|
2014-05-08 |
2023-11-27 |
Kiora Pharmaceuticals Gmbh |
Związki stosowane w leczeniu chorób i schorzeń okulistycznych
|
|
WO2016019506A1
(en)
|
2014-08-05 |
2016-02-11 |
BGI Shenzhen Co.,Limited |
Use of eubacterium in the prevention and treatment for colorectal cancer related diseases
|
|
EP3453396A1
(en)
|
2014-08-28 |
2019-03-13 |
Yale University |
Compositions and methods for treating an inflammatory disease or disorder
|
|
WO2016036615A1
(en)
|
2014-09-03 |
2016-03-10 |
California Institute Of Technology |
Microbe-based modulation of serotonin biosynthesis
|
|
CN104546934B
(zh)
|
2014-09-30 |
2019-04-09 |
深圳华大基因科技有限公司 |
粪副拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546940A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
平常拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546942A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多氏拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546935A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546933A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
粪拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
CN104546932A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
卵形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
|
WO2016057671A1
(en)
|
2014-10-07 |
2016-04-14 |
University Of Virginia Patent Foundation |
Compositions and methods for preventing and treating infection
|
|
EP3209308B1
(en)
|
2014-10-24 |
2022-08-03 |
Evolve Biosystems Inc. |
Activated bifidobacteria and methods of use thereof
|
|
EA201790811A1
(ru)
|
2014-10-30 |
2017-11-30 |
Калифорния Инститьют Оф Текнолоджи |
Содержащие бактерии композиции и способы для улучшения видов поведения при нарушениях неврологического развития
|
|
WO2016069801A1
(en)
|
2014-10-30 |
2016-05-06 |
California Institute Of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodecelopmental disorders
|
|
SG10201903823QA
(en)
|
2014-10-31 |
2019-05-30 |
Whole Biome Inc |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
|
CN104435000A
(zh)
|
2014-11-12 |
2015-03-25 |
江南大学 |
乳酸菌对支气管哮喘治疗中的应用
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
CA3254897A1
(en)
|
2014-11-25 |
2026-03-02 |
Memorial Sloan-Kettering Cancer Center |
Intestinal microbiota and gvhd
|
|
SG11201704814SA
(en)
|
2014-12-23 |
2017-07-28 |
4D Pharma Res Ltd |
Pirin polypeptide and immune modulation
|
|
WO2016102950A1
(en)
|
2014-12-23 |
2016-06-30 |
4D Pharma Research Limited |
Immune modulation
|
|
CN104560820B
(zh)
|
2014-12-30 |
2017-10-20 |
杭州师范大学 |
屎肠球菌kq2.6及应用
|
|
CN107405321A
(zh)
|
2015-01-23 |
2017-11-28 |
坦普尔大学 |
短链脂肪酸在癌症预防中的应用
|
|
CN105982919A
(zh)
|
2015-02-26 |
2016-10-05 |
王汉成 |
生物减速剂抗癌技术
|
|
WO2016139217A1
(en)
|
2015-03-04 |
2016-09-09 |
Ab-Biotics, S.A. |
Composition comprising anaerobically cultivated human intestinal microbiota
|
|
US20160271189A1
(en)
|
2015-03-18 |
2016-09-22 |
Whole Biome, Inc. |
Methods and compositions relating to microbial treatment and diagnosis of skin disorders
|
|
US20180078587A1
(en)
|
2015-03-18 |
2018-03-22 |
Trustees Of Tufts College |
Compositions and methods for preventing colorectal cancer
|
|
BR112017025813A2
(pt)
|
2015-06-01 |
2018-08-14 |
Univ Chicago |
método, kit ou composição, micróbio comensal benéfico, método para tratar ou prevenir o câncer e formulação bacteriana
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
ME03511B
(me)
|
2015-06-15 |
2020-04-20 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
|
HRP20191949T1
(hr)
|
2015-06-15 |
2020-01-24 |
4D Pharma Research Limited |
Blautia stercosis i wexlerae za upotrebu u liječenju upalnih i autoimunih bolesti
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
WO2016203221A1
(en)
|
2015-06-15 |
2016-12-22 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
CN105112333A
(zh)
|
2015-08-31 |
2015-12-02 |
江南大学 |
一种具有良好肠道定殖能力的长双歧杆菌及筛选方法和应用
|
|
HK1254843B
(zh)
|
2015-11-20 |
2020-04-17 |
希杰生物科技株式会社 |
包含细菌菌株的组合物
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
WO2017091753A1
(en)
|
2015-11-25 |
2017-06-01 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization
|
|
SG10201913557TA
(en)
|
2016-03-04 |
2020-02-27 |
4D Pharma Plc |
Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
|
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商４Ｄ製藥有限公司 |
包含細菌菌株之組合物
|
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
WO2018112365A2
(en)
|
2016-12-16 |
2018-06-21 |
Evelo Biosciences, Inc. |
Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
|
|
US20190314427A1
(en)
|
2016-12-16 |
2019-10-17 |
Evelo Biosciences, Inc. |
Methods of treating cancer using parabacteroides
|
|
EP3630942B1
(en)
|
2017-05-24 |
2022-11-30 |
4D Pharma Research Limited |
Compositions comprising bacterial strain
|
|
MA51770A
(fr)
|
2017-07-05 |
2020-05-13 |
Evelo Biosciences Inc |
Compositions et méthodes de traitement du cancer à l'aide de bifidobacterium animalis ssp. lactis
|